The ability of magnetic resonance imaging to predict lymph node metastases and the risk of recurrence in rectal cancer.

MRI detected lymph node positivity appears insufficiently precise and cannot predict disease recurrence or survival. Therefore, it should not serve as an independent risk factor when considering neoadjuvant treatment options for rectal cancer patients.